By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Canada 

2365 Côte-de-Liesse
St-Laurent Borough
Montreal  Quebec    Canada
Phone: 514-333-3200 Fax: n/a


SEARCH JOBS








Company News
Bristol-Myers Squibb Canada (BMY) Release: First-Ever Combination Of Two Immuno-Oncology Agents For Metastatic Melanoma Approved By Health Canada 11/1/2016 7:50:59 AM
Bristol-Myers Squibb Canada (BMY) Release: Canada's Health Technology Assessment Agency Gives Positive Recommendation For OPDIVO To Treat Non-Small Cell Lung Cancer 6/9/2016 10:01:37 AM
Bristol-Myers Squibb Canada (BMY) Release: Health Canada Approves DAKLINZA (Daclatasvir) For Difficult-To-Treat Hepatitis C Patient Populations 5/24/2016 6:23:19 AM
Bristol-Myers Squibb Canada (BMY) Release: Health Canada Approves OPDIVO (nivolumab) For The Treatment Of Advanced Or Metastatic Non-Small Cell Lung Cancer 3/1/2016 8:16:40 AM
Roche (RHHBY) Should Head Back to the Acquisition Trail, Abbvie or Bristol-Myers Squibb Canada (BMY) Should be Targeted: Analyst 9/28/2012 8:32:29 AM
FDA Approves Bristol-Myers Squibb Canada (BMY)'s Self-injectable Form of RA Therapy Orencia 8/1/2011 6:54:18 AM
Bristol-Myers Squibb Canada (BMY) Relocates to Technoparc Montreal 3/19/2009 7:44:58 AM
Bristol-Myers Squibb Canada (BMY) Commercializes ERBITUX(TM) for Advanced Colorectal Cancer 10/29/2008 4:25:34 PM
ImClone Systems Incorporated (IMCL) Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer 10/29/2008 9:24:15 AM
Bristol-Myers Squibb Canada (BMY) Profit Triples on Sale of Device Unit 10/23/2008 6:34:48 AM
12
//-->